$
63. 60
-1.6
-2.454%
$
207.27M Market Cap
0.28% Div Yield
41,705 Volume
$ 65.2
Previous Close 
Want to track SBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Returns Spiking for This Rate-Sensitive ETF
On the lookout for an ETF that might respond particularly well to rate cuts? One rate-sensitive ETF to watch is seeing returns spike even before rate cuts arrive.
Etftrends | 2 years ago
Patent Cliffs Could Spark Wave of Biotech M&A
There's long been talk of a new wave of biotech mergers and acquisitions activity coming to life. In modest amounts, there has been evidence of that playing out.
Etftrends | 2 years ago
Big Pharma Has the Firepower for Biotech Deal-Making
In the early innings of 2024, there was a flurry of consolidation in the biotech industry. It stoked hopes that this would finally be the year in which well-heeled blue-chip pharmaceutical companies would spend some of their cash on faster-growing biotech firms.
Etftrends | 2 years ago
